Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Faron Pharma Share Price
  4. Faron Pharma Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksFaron Pharma Share News (FARN)

Faron Pharma Information

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 238.00
Bid: 230.00
Ask: 246.00
Change: -27.00 (-10.19%)
Spread: 16.00 (6.957%)
Open: 265.00
High: 265.00
Low: 237.00
Prev. Close: 238.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 18th Mar 2021 16:06

Friday 19 March 
Sanne Group PLCFull Year Results
Investec PLCTrading Statement
Johnson Service Group PLCFull Year Results
JD Wetherspoon PLCHalf Year Results
ContourGlobal PLCFull Year Results
Monday 22 March 
Blackbird PLCFull Year Results
Yew Grove REIT PLCFull Year Results
Centamin PLCFull Year Results
Kingfisher PLCFull Year Results
SDX Energy PLCFull Year Results
Tuesday 23 March 
accesso Technology Group PLCFull Year Results
Alliance Pharma PLCFull Year Results
Arrow Global Group PLCFull Year Results
Cambridge Cognition PLCFull Year Results
DP Eurasia NVFull Year Results
Elementis PLCFull Year Results
Energean PLCFull Year Results
essensys PLCFull Year Results
Fintel PLCFull Year Results
Gamma Communications PLCFull Year Results
H&T Group PLCFull Year Results
Henry Boot PLCFull Year Results
Judges Scientific PLCFull Year Results
Longboat Energy PLCFull Year Results
LoopUp Group PLCFull Year Results
Luceco PLCFull Year Results
Malin Corp PLCFull Year Results
McColl's Retail Group PLCFull Year Results
MJ Hudson Group PLCHalf Year Results
Mortgage Advice Bureau Holdings PLCFull Year Results
MP Evans Group PLCFull Year Results
Old Mututal LtdFull Year Results
Personal Group Holdings PLCFull Year Results
YouGov PLCFull Year Results
Zotefoams PLCFull Year Results
Wednesday 24 March 
Softcat PLCHalf Year Results
Circassia Group PLCFull Year Results
Burford Capital LtdFull Year Results
Sopheon PLCFull Year Results
Strix Group PLCFull Year Results
TClarke PLCFull Year Results
Keywords Studios PLCFull Year Results
ECSC Group PLCFull Year Results
Telit Communications PLCFull Year Results
Bellway PLCHalf Year Results
Diploma PLCTrading Statement
Anglo Pacific Group PLCFull Year Results
Frontier IP Group PLCHalf Year Results
Pendragon PLCFull Year Results
Applied Graphene Materials PLCHalf Year Results
Kenmare Resources PLCFull Year Results
Thursday 25 March 
Allied Minds PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Biome Technologies PLCFull Year Results
Cineworld Group PLCFull Year Results
Compass Group PLCTrading Statement
CVS Group PLCHalf Year Results
EnQuest PLCFull Year Results
Equiniti Group PLCFull Year Results
Faron Pharmaceuticals OyFull Year Results
Funding Circle Holdings PLCFull Year Results
Genedrive PLCHalf Year Results
International Public Partnerships LtdFull Year Results
IQE PLCFull Year Results
Lamprell PLCFull Year Results
Learning Technologies Group PLCFull Year Results
Pebble Group PLCFull Year Results
Robinson PLCFull Year Results
S4 Capital PLCFull Year Results
Safestyle UK PLCFull Year Results
SIG PLCFull Year Results
Surgical Innovations Group PLCFull Year Results
United Utilities Group PLCTrading Statement
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Jun 2019 11:52

Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use

(Alliance News) - Faron Pharmaceuticals Oy on Wednesday said interim results from its phase two Inforaaa study support continuation but the study is limited by a lack of patients not also taking a

Read more
14 Jun 2019 11:54

Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial

(Alliance News) - Faron Pharmaceuticals Oy on Friday said analysis of a more recent trial of Traumakine has explained why the drug did not perform as expected in a previous trial.Shares in

Read more
14 Jun 2019 10:37

Faron Pharmaceuticals reports 'significant' findings from YODA study

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced results from its pharmacokinetic/dynamic 'YODA' study examining the administration of concomitant steroids and Traumakine in healthy volunteers on Friday.

Read more
24 May 2019 13:34

Faron Pharma Finance Head Wichmann Steps Down, Hanninen Replaces

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Friday said it has made several managerial changes, which it believes will strengthen its operating performance.The clinical stage said

Read more
24 May 2019 11:50

Faron appoints new CFO after some internal shuffling

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals updated the market on its board and management team on Friday, announcing that Yrjö Wichmann was leaving his current role as its chief financial officer to take up the new position of vice-president, financing and investor relations.

Read more
14 May 2019 14:16

Faron Pharmaceuticals Raises EUR1.3 Million Via Share Subscription (ALLISS)

LONDON (Alliance News) - Biopharmaceutical company Faron Pharmaceuticals Ltd said Tuesday that it has raised EUR1.3 million via share subscription.The company has issued 1.8 million shares

Read more
7 May 2019 11:44

Faron Pharmaceuticals Narrows Loss On Reduced Clinical Trial Costs

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Tuesday reported a slightly narrowed annual loss as the drug developer's research & development costs fell.Faron is a clinical

Read more
2 May 2019 17:30

Faron Pharmaceuticals Knows Of No Reason For 43% Share Price Jump

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it is unable to explain the recent movement in its share price.Faron noted Thursday's 43% share price rise, and said

Read more
30 Apr 2019 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 1 May J SainsburyFull Year ResultsConnect GroupHalf Year GroupQ1 Stock

Read more
29 Apr 2019 15:46

Faron Gets Results Of Traumakine Study From Japanese Licensing Partner

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said its Japanese licensing partner Maruishi Pharmaceutical Co Ltd has provided clinical trial results on its phase three Traumakine for

Read more
11 Apr 2019 12:13

Faron Pharmaceuticals To Focus On Colorectal Cancer In Clevegen Trial

LONDON (Alliance News) - Faron Pharmaceuticals Oy is to target colorectal cancer in its upcoming test programme for Clevegen, it said Thursday.The testing of Clevegen on patients with will

Read more
11 Apr 2019 11:22

Faron Pharmaceuticals upbeat on latest info from MATINS trial

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Thursday that the cohort expansion part of its phase 1 and 2 'MATINS' clinical trial, investigating the safety and efficacy of its wholly-owned novel precision cancer immunotherapy 'Clevegen', would begin with patients suffering from late-stage colorectal cancer as soon as the optimal dosing was determined.

Read more
26 Mar 2019 15:52

UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday afternoon said it has raised EUR3.1 million pursuant to a placing announced earlier in the day.The company issued

Read more
26 Mar 2019 12:05

Faron Pharmaceuticals Optimistic For Traumakine As It Plans Fundraise (ALLISS)

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday said it expects further disappointing results from Traumakine, as it plans a share placing.Faron is currently for

Read more
21 Feb 2019 12:17

Faron "Very Encouraged" By Early Clevegen Trials In Cancer Patients

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said early results from a trial of its Clevegen cancer drug are encouraging.Shares in Faron were up 10% at 64.00 pence on said

Read more
6789101112131415

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.